NCT06724575View on ClinicalTrials.gov

EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece

Active, not recruitingOBSERVATIONAL
Enrollment

154

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Asthma
Trial Locations (8)

Unknown

Research Site, Alexandroupoli

Research Site, Athens

Research Site, Corfu

Research Site, Crete

Research Site, Ioannina

Research Site, Larissa

Research Site, Pátrai

Research Site, Thessaloniki

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY